Novo sued for Teva deal to delay generic Victoza

 Novo Nordisk (NVO) faces a class action suit over claims it ran a pay-for-delay deal with Teva (TEVA) to delay generics for its diabetes drug.

https://seekingalpha.com/news/4542260-novo-sued-teva-deal-delay-generic-victoza